11-56577213-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004741.1(OR5M10):c.509G>A(p.Gly170Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004741.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5M10 | NM_001004741.1 | c.509G>A | p.Gly170Asp | missense_variant | 1/1 | ENST00000526538.2 | NP_001004741.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5M10 | ENST00000526538.2 | c.509G>A | p.Gly170Asp | missense_variant | 1/1 | 6 | NM_001004741.1 | ENSP00000435416.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151946Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249168Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135160
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461692Hom.: 0 Cov.: 33 AF XY: 0.0000454 AC XY: 33AN XY: 727132
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152064Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.509G>A (p.G170D) alteration is located in exon 1 (coding exon 1) of the OR5M10 gene. This alteration results from a G to A substitution at nucleotide position 509, causing the glycine (G) at amino acid position 170 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at